Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 82.83% |
| 2 | Healthcare | 3.13% |
| 3 | Technology | 2.97% |
| 4 | Financials | 2.19% |
| 5 | Consumer Discretionary | 2.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
MRSN
12026
CALL
DELISTED
Mersana Therapeutics
MRSN
| $65.6K | ﹤0.01% |
1,836
+748
| +69% | +$38.7K |
2022 Q4
8 quarters
|
|
|
SCHR
12027
CALL
Schwab Intermediately-Term US Treasury ETF
SCHR
$13.1B
| $65.6K | ﹤0.01% |
2,700
+300
| +13% | +$7.38K |
2023 Q1
7 quarters
|
|
12028
PUT
Global X FinTech ETF
FINX
$157M
| $65.6K | ﹤0.01% |
+2,100
| New | +$65.6K |
2024 Q4
0 quarters
|
|
|
CDMO
12029
CALL
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $65.5K | ﹤0.01% |
5,300
-22,000
| -81% | -$252K |
2021 Q1
15 quarters
|
|
12030
Solventum
SOLV
$14.7B
| $65.2K | ﹤0.01% |
+987
| New | +$69.1K |
2024 Q4
0 quarters
|
|
12031
CALL
InfuSystem Holdings
INFU
$268M
| $65.1K | ﹤0.01% |
7,700
+5,800
| +305% | +$45.7K |
2022 Q4
8 quarters
|
|
12032
PennantPark Floating Rate Capital
PFLT
$656M
| $65K | ﹤0.01% |
5,947
-27,293
| -82% | -$306K |
2022 Q3
9 quarters
|
|
12033
CALL
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
$40.8B
| $64.8K | ﹤0.01% |
+1,900
| New | +$68K |
2024 Q4
0 quarters
|
|
|
12034
PUT
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
$40.8B
| $64.8K | ﹤0.01% |
+1,900
| New | +$68K |
2024 Q4
0 quarters
|
|
12035
Rapid Micro Biosystems
RPID
$46.3M
| $64.8K | ﹤0.01% |
+72,024
| New | +$72.5K |
2024 Q4
0 quarters
|
|
12036
CALL
Reynolds Consumer Products
REYN
$4.66B
| $64.8K | ﹤0.01% |
2,400
-4,000
| -63% | -$113K |
2020 Q3
17 quarters
|
|
12037
CALL
Editas Medicine
EDIT
$432M
| $64.8K | ﹤0.01% |
51,000
-7,000
| -12% | -$17.8K |
2017 Q1
31 quarters
|
|
|
OTLY
12038
PUT
Oatly Group
OTLY
$336M
| $64.8K | ﹤0.01% |
4,885
-555
| -10% | -$8.18K |
2021 Q2
14 quarters
|
|
12039
PUT
MidCap Financial Investment
MFIC
$693M
| $64.8K | ﹤0.01% |
4,800
-7,000
| -59% | -$95K |
2019 Q4
20 quarters
|
|
12040
PUT
Ambev
ABEV
$48.9B
| $64.8K | ﹤0.01% |
35,000
+4,100
| +13% | +$9.07K |
2020 Q1
19 quarters
|
|
|
RPT
12041
CALL
Rithm Property Trust
RPT
$83M
| $64.7K | ﹤0.01% |
3,633
-2,800
| -44% | -$51.6K |
2022 Q3
9 quarters
|
|
12042
CALL
Pyxis Oncology
PYXS
$169M
| $64.7K | ﹤0.01% |
41,500
+31,900
| +332% | +$92K |
2023 Q4
4 quarters
|
|
|
KG
12043
CALL
Kestrel Group
KG
$40.2M
| $64.7K | ﹤0.01% |
1,915
+1,865
| +3,730% | +$59.6K |
2024 Q3
1 quarter
|
|
12044
PUT
Consolidated Water Co
CWCO
$483M
| $64.7K | ﹤0.01% |
2,500
-3,100
| -55% | -$78.9K |
2022 Q4
8 quarters
|
|
12045
PUT
Amprius Technologies
AMPX
$1.32B
| $64.7K | ﹤0.01% |
23,100
+16,000
| +225% | +$28K |
2023 Q3
5 quarters
|
|
12046
PUT
DMC Global
BOOM
$118M
| $64.7K | ﹤0.01% |
8,800
+1,400
| +19% | +$13.2K |
2022 Q2
10 quarters
|
|
12047
CALL
Cohen & Steers
CNS
$3.68B
| $64.6K | ﹤0.01% |
700
+500
| +250% | +$49.5K |
2022 Q4
8 quarters
|
|
12048
Central Pacific Financial
CPF
$925M
| $64.6K | ﹤0.01% |
2,224
-6,707
| -75% | -$200K |
2024 Q3
1 quarter
|
|
12049
PUT
Phunware
PHUN
$41.5M
| $64.6K | ﹤0.01% |
+12,420
| New | +$68.5K |
2024 Q4
0 quarters
|
|
|
WALD
12050
DELISTED
Waldencast
WALD
| $64.6K | ﹤0.01% |
+16,065
| New | +$56.4K |
2024 Q4
0 quarters
|
|
Similar funds
Citadel Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, Citadel Advisors held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Citadel Advisors's Q4 2024 filing shows 1,745 new, 6,427 increased, 6,082 reduced and 1,421 closed positions. Its largest new stake was Zoetis: 1,090,499 shares worth $178M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, down from 83% a quarter earlier, followed by Healthcare and Technology.
- Citadel Advisors's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Citadel Advisors added most to Boeing in Q4 2024, an estimated $830M increase.
- Citadel Advisors's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Citadel Advisors fully exited Spotify in Q4 2024, selling an estimated $473M.
- Citadel Advisors's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Citadel Advisors opened 1,745 new positions and closed 1,421 in Q4 2024.
- Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.